Published in Clin Exp Immunol on April 01, 1982
Thyroid autoantibody synthesis by cultures of thyroid and peripheral blood lymphocytes. I. Lymphocyte markers and response to pokeweed mitogen. Clin Exp Immunol (1983) 1.34
Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc Natl Acad Sci U S A (1991) 1.33
Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. J Clin Invest (1990) 1.17
Thyroid autoantibody synthesis by lymphocytes from different lymphoid organs: fractionation of B cells on density gradients. Immunology (1985) 1.02
Intrathyroidal lymphocyte subsets, including unusual CD4+ CD8+ cells and CD3loTCR alpha beta lo/-CD4-CD8- cells, in autoimmune thyroid disease. Clin Exp Immunol (1993) 1.01
Severe combined immunodeficient (SCID) mice: a model for investigating human thyroid autoantibody synthesis. Clin Exp Immunol (1991) 0.95
Extrathyroidal sites of autoantibody synthesis in Graves' disease. Clin Exp Immunol (1984) 0.91
Characterization of lymphoid cells in the thyroid of patients with Graves' disease. Clin Exp Immunol (1984) 0.91
Subpopulations of thyroid autoantibody secreting lymphocytes in Graves' and Hashimoto thyroid glands. Clin Exp Immunol (1986) 0.89
Studies on the immunoregulation of thyroid autoantibody production in vitro. Clin Exp Immunol (1985) 0.88
Functional analysis of T and B cells from blood and thyroid tissue in Hashimoto's disease. Clin Exp Immunol (1985) 0.88
Spontaneous secretion of thyroid autoantibodies by cultured peripheral blood lymphocytes from patients with Hashimoto's thyroiditis detected by micro-ELISA techniques. Clin Exp Immunol (1984) 0.87
Asialoagalactothyroglobulin binds to the surface of human thyroid cells at a site distinct from the 'microsomal' autoantigen. Clin Exp Immunol (1984) 0.81
Heterogeneity of the immune status concerning anti-thyroglobulin antibody production among patients with Hashimoto's thyroiditis; an in vitro study. Clin Exp Immunol (1988) 0.78
Changes in anti-thyroglobulin IgG glycosylation patterns in Hashimoto's thyroiditis patients. J Clin Endocrinol Metab (2014) 0.77
Thyroid stimulating immunoglobulin (TSI) synthesis by pokeweed mitogen (PWM) stimulated peripheral blood lymphocytes (PBL) from Graves' disease (GD) patients. Clin Exp Immunol (1986) 0.75
Associations of melatonin receptor gene polymorphisms with Graves' disease. PLoS One (2017) 0.75
A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol (1976) 9.11
Carbimazole and the autoimmune response in Graves' disease. N Engl J Med (1980) 2.62
Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Lancet (1975) 2.57
Analysis by a plaque assay of IgG- or IgM- dependent cytolytic lymphocytes in human blood. J Exp Med (1976) 1.69
Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: studies of seventy autopsied cases. J Clin Endocrinol Metab (1978) 1.60
Distribution of T-, B-, and thyroglobulin-binding lymphocytes infiltrating the gland in Graves' disease, Hashimoto's thyroiditis, and de Quervain's thyroiditis. Clin Immunol Immunopathol (1978) 1.53
Thyroid-autoantibody synthesis by Hashimoto thyroid lymphocytes. Lancet (1979) 1.52
Immunoregulation in autoimmunity. J Allergy Clin Immunol (1980) 1.52
Use of plaque assays to study thyroglobulin autoantibody synthesis by human peripheral blood lymphocytes. Scand J Immunol (1981) 1.39
Induction of antibody synthesis in human B lymphocytes by different polyclonal B cell activators: evaluation by direct and indirect PFC assays. Immunol Rev (1979) 1.10
The protein-A plaque assay: a new system for the detection of cells secreting a given idiotype. J Immunol (1980) 0.94
Spontaneous plaque-forming human lymphocytes detected with the protein-A plaque assay. Scand J Immunol (1980) 0.87
The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) (1977) 9.53
Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med (1994) 5.19
A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med (1998) 4.81
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Radioimmunoassay of human serum thyrotrophin. Br Med J (1971) 4.59
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
Thyrotrophin-releasing hormone as a thyroid-function test. Lancet (1971) 4.34
Grades of hypothyroidism. Br Med J (1973) 3.30
Vitiligo, thyroid disease and autoimmunity. Br J Dermatol (1968) 3.18
The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet (1972) 3.10
Thyroid-stimulating immunoglobulins in Graves' disease. Lancet (1974) 2.84
Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria. Nature (1984) 2.74
Circulating sensitised lymphocytes in Graves' disease. Observations on its pathogenesis. Lancet (1970) 2.73
Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer Research. BMJ (1994) 2.70
Hopping hotspots: global shifts in marine biodiversity. Science (2008) 2.68
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Carbimazole and the autoimmune response in Graves' disease. N Engl J Med (1980) 2.62
Association between Graves' ophthalmopathy and smoking. Lancet (1990) 2.62
Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Lancet (1975) 2.57
Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect Immun (1997) 2.50
Computerised updating of clinical summaries: new opportunities for clinical practice and research? BMJ (1988) 2.49
Bromocriptine therapy in acromegaly. Lancet (1975) 2.42
Cyclosporin improves Graves' ophthalmopathy. Lancet (1983) 2.32
Treatment of hypothyroidism: a reappraisal of thyroxine therapy. Br Med J (1973) 2.30
Autoimmune thyroid disease: further developments in our understanding. Endocr Rev (1994) 2.19
Changing patterns of self-poisoning in a UK health district. QJM (1996) 2.13
Postpartum thyroid dysfunction. Thyroid (1992) 2.03
Antigens of the erythrocytes stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies. Mol Biochem Parasitol (1983) 2.00
Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) (1981) 1.99
Autoimmune thyroid disease: developments in our understanding. Endocr Rev (1984) 1.98
Clinical pathology testing recommendations for nonclinical toxicity and safety studies. AACC-DACC/ASVCP Joint Task Force. Toxicol Pathol (1992) 1.94
Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat Genet (1998) 1.91
Aggregative adherence fimbria I expression in enteroaggregative Escherichia coli requires two unlinked plasmid regions. Infect Immun (1993) 1.89
Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ (1992) 1.86
Letter: Complication of proximal gastric vagotomy. Br Med J (1974) 1.82
Trial of strategy for reducing the use of laboratory tests. Br Med J (Clin Res Ed) (1986) 1.82
Life-threatening arrhythmias and intravenous cimetidine. Br Med J (1979) 1.81
Thyroid-stimulating hormone response to synthetic thyrotrophin releasing hormone in man. Br Med J (1970) 1.79
Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med (1991) 1.78
Effusions into body cavities in hypothyroidism. Lancet (1975) 1.77
High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol (2001) 1.74
Serum-thyrotropin levels after subtotal thyroidectomy for Graves' disease. Lancet (1971) 1.73
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol (Oxf) (2002) 1.71
Simple method of assessing splenic function in coeliac disease. Clin Sci (Lond) (1981) 1.70
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet (1973) 1.68
Prediction of outcome in Graves' disease after carbimazole treatment. Q J Med (1986) 1.68
Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J (1973) 1.66
Effects of bromocriptine on pituitary tumour size. Br Med J (1979) 1.64
Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH FSH-RH, TRH and hypoglycaemia alone and in combination. Clin Endocrinol (Oxf) (1973) 1.60
Meningococcal disease in Wales: clinical features, outcome and public health management. J Infect (1992) 1.60
Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J (2002) 1.59
A systematic approach to erectile dysfunction in the cardiovascular patient: a Consensus Statement--update 2002. Int J Clin Pract (2002) 1.58
The utility of radioiodine uptake and thyroid scintigraphy in the diagnosis and management of hyperthyroidism. Clin Endocrinol (Oxf) (2009) 1.57
Treatment of hyperthyroidism by radioactive iodine. Summary of a UK national survey prepared for the Royal College of Physicians Committee on Endocrinology and Diabetes. J R Coll Physicians Lond (1992) 1.56
Thyroid-autoantibody synthesis by Hashimoto thyroid lymphocytes. Lancet (1979) 1.52
Ribosomal RNA sequences of Sarcocystis muris, Theileria annulata and Crypthecodinium cohnii reveal evolutionary relationships among apicomplexans, dinoflagellates, and ciliates. Mol Biochem Parasitol (1991) 1.51
A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement. Int J Clin Pract (1999) 1.51
Confirming the drugs administered during anaesthesia: a feasibility study in the pilot National Health Service sites, UK. Br J Anaesth (2010) 1.50
Myopathy in acromegaly. Lancet (1970) 1.50
Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf) (1977) 1.49
Smoking cessation: a consensus statement with special reference to primary care. Int J Clin Pract (2001) 1.48
The nadir growth hormone after an octreotide test dose predicts the long-term efficacy of somatostatin analogue therapy in acromegaly. Clin Endocrinol (Oxf) (2005) 1.47
The immunoassay of thyroid-stimulating hormone and its clinical applications. Clin Endocrinol (Oxf) (1972) 1.47
Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) (1980) 1.46
The immunomodulatory effects of antithyroid drugs. Thyroid (1994) 1.45
DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology (1998) 1.42
The evaluation of patients with a suspected pituitary microadenoma: computer tomography compared to magnetic resonance imaging. Clin Endocrinol (Oxf) (1992) 1.41
Hypothyroidism. Br Med J (1972) 1.41
Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema. J Clin Endocrinol Metab (1995) 1.41
The in vitro regulation of human thyrocyte HLA-DR antigen expression. J Clin Endocrinol Metab (1985) 1.40
A clinical evaluation of the Accutracker--a lightweight ambulatory blood pressure monitor. J Hum Hypertens (1989) 1.39
Is Graves' dermopathy a generalized disorder? Thyroid (1996) 1.39
Catheter ablation of the atrioventricular node using radiofrequency energy. Aust N Z J Med (1994) 1.39
Graves' disease by any other name? Thyroid (2000) 1.39
Use of plaque assays to study thyroglobulin autoantibody synthesis by human peripheral blood lymphocytes. Scand J Immunol (1981) 1.39
Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics (2001) 1.38
The thyroid and pregnancy. Br J Obstet Gynaecol (1993) 1.38
Categorical and noncategorical modes of speech perception along the voicing continuum. J Acoust Soc Am (1974) 1.37
Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endocrinol Metab (2006) 1.37
Processing, polymorphism, and biological significance of P190, a major surface antigen of the erythrocytic forms of Plasmodium falciparum. Mol Biochem Parasitol (1984) 1.37
History of dermatology in Northern Ireland. Br J Dermatol (1970) 1.36
Characterization of myosin light chains from histochemically identified fibres of rabbit psoas muscle. FEBS Lett (1975) 1.35
Autoimmunity as an aetiological factor in vitiligo. J Eur Acad Dermatol Venereol (2007) 1.34
The effect of calcium ions on the binomial statistic parameters which control acetylcholine release at synapses in striated muscle. J Physiol (1975) 1.33
Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke. Neurology (2011) 1.33
Evidence for immunological cross-reaction between sporozoites and blood stages of a human malaria parasite. Nature (1984) 1.33
Lithium therapy and thyroid function: a long-term study. Psychol Med (1981) 1.32